Literature DB >> 27057652

Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.

Ping Yuan1, Qipeng Sun2, Hao Liang3,4, Wenjun Wang1, Ling Li1, Ye Wang5, Huan Deng6, Luhua Lai3,4, Xiaoli Chen1, Xiangfu Zhou2.   

Abstract

Von Hippel-Lindau (VHL) disease is a rare autosomal dominant inherited cancer syndrome that is characterized by hemangioblastomas in the central nervous system and retina, renal cell carcinoma and cysts, pancreatic tumors and cysts, and pheochromocytoma. The underlying gene in this disease is the VHL tumor suppressor gene. We characterized a family with 2 affected siblings. The brother and sister displayed VHL type 2B and type 2A features, respectively. Renal lesions in the brother exhibited 3 different phenotypes, including simple renal cysts, multilocular cystic renal cell carcinoma and clear cell renal cell carcinoma. The phenotypes of the 3 concurrent renal lesions were first reported in this study. Mutation detection of the VHL gene revealed 2 recurrent mutations, namely c.256C>T (p.P86S) and c.340 + 5G > C. The former was predicted to be deleterious and to destabilize the hydrophobic core and lead to VHL dysfunction; however, the latter was predicted to be a benign variant. Our findings provided new data for the genotype-phenotype of VHL diseases and elucidated the pathogenic mechanism with in silico analysis.

Entities:  

Keywords:  Clear cell renal cell carcinoma; VHL; multilocular cystic renal cell carcinoma; mutation; von Hippel–Lindau disease

Mesh:

Substances:

Year:  2016        PMID: 27057652      PMCID: PMC4990403          DOI: 10.1080/15384047.2016.1167293

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

1.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma.

Authors:  Shams Halat; John N Eble; David J Grignon; Antonio Lopez-Beltran; Rodolfo Montironi; Puay-Hoon Tan; Mingsheng Wang; Shaobo Zhang; Gregory T MacLennan; Liang Cheng
Journal:  Mod Pathol       Date:  2010-03-26       Impact factor: 7.842

3.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

4.  Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Authors:  Zoran Erlic; Michael M Hoffmann; Maren Sullivan; Gerlind Franke; Mariola Peczkowska; Igor Harsch; Matthias Schott; Helmut E Gabbert; Matti Valimäki; Simon F Preuss; Kornelia Hasse-Lazar; Dariusz Waligorski; Mercedes Robledo; Andrzej Januszewicz; Charis Eng; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 5.  The von Hippel-Lindau tumor suppressor gene and kidney cancer.

Authors:  William G Kaelin
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

6.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

Review 7.  Von Hippel-Lindau disease.

Authors:  William G Kaelin
Journal:  Annu Rev Pathol       Date:  2007       Impact factor: 23.472

8.  Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

Authors:  P A Crossey; F M Richards; K Foster; J S Green; A Prowse; F Latif; M I Lerman; B Zbar; N A Affara; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

9.  The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.

Authors:  P L Choyke; G M Glenn; M M Walther; B Zbar; G H Weiss; R B Alexander; W S Hayes; J P Long; K N Thakore; W M Linehan
Journal:  AJR Am J Roentgenol       Date:  1992-12       Impact factor: 3.959

10.  An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.

Authors:  Lucy Gossage; Douglas E V Pires; Álvaro Olivera-Nappa; Juan Asenjo; Mark Bycroft; Tom L Blundell; Tim Eisen
Journal:  Hum Mol Genet       Date:  2014-06-26       Impact factor: 6.150

View more
  2 in total

1.  In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.

Authors:  Amit Tirosh; Mustapha El Lakis; Patience Green; Pavel Nockel; Dhaval Patel; Naris Nilubol; Sudheer Kumar Gara; Xavier M Keutgen; W Marston Linehan; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

2.  Von Hippel-Lindau "Black Forest" mutation inherited in a large Chinese family.

Authors:  Peihua Liu; Feizhou Zhu; Minghao Li; Daud Athanasius Dube; Qianqian Liu; Cikui Wang; Qiao Xiao; Liang Zhang; Shuai Gao; Zhuolin Li; Bo Zhang; Jing Liu; Longfei Liu; Xiang Chen
Journal:  Gland Surg       Date:  2019-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.